University of Aberdeen team suggest results indicate that protein PAI-1 could be an early indicator of severe COVID-19
University of Aberdeen team suggest results indicate that protein PAI-1 could be an early indicator of severe COVID-19
Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the UK
Partnership will focus on the discovery of novel targets in Alzheimer’s disease
Chronic obstructive pulmonary disease phase 3 study shows statistically significant improvements in lung function
Patents show potential of innovative Arestat technology and the development of enhanced formulations
Positive data show Pentarlandir is safe and effective in patients with mild-to-moderate COVID-19
Study involved patients with locally advanced, unresectable stage 3 non-small cell lung cancer
Better Meds is already removing paper forms and manual processes from NHS Trust’s system
Partnership will accelerate development of oncology medicines and expand presence in China
Senior NHS figures fear that the leadership contest is not addressing wider health service needs
Candidate exhibits a novel mechanism of action and differs considerably from previously approved drugs
Deal represents part of Boehringer Ingelheim’s strategy to provide breakthrough cancer therapies
The sites will maximise local and global benefits of NHS, research, industry and community partnerships
Unique skin symptoms of the current monkeypox outbreak include pseudo-pustules
System improves management for people with diabetes by offering finger prick-free monitoring